Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01QKX
|
|||
Former ID |
DNC008557
|
|||
Drug Name |
(5Z,9Z)-5,9-heptacosadienoic acid
|
|||
Synonyms |
(5Z,9Z)-5,9-heptacosadienoic acid; 5Z,9Z-heptacosadienoic acid; CHEMBL463437; 27:2(5Z,9Z); LMFA01020363
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C27H50O2
|
|||
Canonical SMILES |
CCCCCCCCCCCCCCCCCC=CCCC=CCCCC(=O)O
|
|||
InChI |
1S/C27H50O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26-27(28)29/h18-19,22-23H,2-17,20-21,24-26H2,1H3,(H,28,29)/b19-18-,23-22-
|
|||
InChIKey |
QHCUSXRHMXVISV-ZCIBKELESA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | DNA topoisomerase I (TOP1) | Target Info | Inhibitor | [1] |
NetPath Pathway | IL2 Signaling Pathway | |||
Panther Pathway | DNA replication | |||
Pathway Interaction Database | Caspase Cascade in Apoptosis | |||
WikiPathways | Integrated Pancreatic Cancer Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Total synthesis and biological evaluation of (5Z,9Z)-5,9-hexadecadienoic acid, an inhibitor of human topoisomerase I. J Nat Prod. 2002 Nov;65(11):1715-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.